Tuesday 07 April 2020 - 06:02
In Business 40 Years - Since 1980
Online ordering via the shopping cart is working again on our web site! We have solved the technical issues on our servers and want to assure our valuable customers that the updates made will ensure that your personal and credit card information continue to remain secure. We apologize for any difficulties you may have encountered during this time.
FREE SHIPPING TO THE U.S. AND 32 OTHER COUNTRIES! [Read more].
Search:
D-3608 Dovitinib, Free Base, >99%
Synonyms : [CHIR-258] [TKI-258]
- Size
- US $
- €
- £
- ¥
- 10 mg
- 85
- 78
- 69
- 9,300
- In stock
- 25 mg
- 175
- 162
- 142
- 19,100
- In stock
- 50 mg
- 266
- 246
- 215
- 29,000
- In stock
- 100 mg
- 445
- 412
- 361
- 48,600
- In stock
- 200 mg
- 790
- 731
- 641
- 86,200
- In stock
- 500 mg
- 1,350
- 1,250
- 1,096
- 147,300
- In stock
- 1 g
- 2,250
- 2,083
- 1,827
- 245,500
- In stock
Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.
To receive a Formal Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities
Free Shipping and Handling to the U.S. and 33 Other Countries
- M.W. 392.43
- C21H21FN6O
- [405169-16-6]
Storage: Store at or below -20 ºC. Solubility: Soluble in DMSO. Disposal: A.
- This is the free base form of dovitinib; please see our product Dovitinib, Lactate Salt, Cat. No. D-3699 for further technical information. The lactate salt form of dovitinib, not the free base, is used in the dovitinib formulation for biomedical research.
- Sold for laboratory or manufacturing purposes only; not for human, medical, veterinary, food, or household use.
- This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
- Not available in some countries; not available to some institutions; not available for some uses.
